Currency in INR
Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 2 | 1 | 14 | 16 |
Avg. Estimate | 1.3 | 1.19 | 6.26 | 8.05 |
Low estimate | 0.6 | 1.19 | 1.51 | 4.4 |
High estimate | 2.01 | 1.19 | 9.08 | 10.93 |
Year ago EPS | 2.59 | 0.85 | 3.84 | 6.26 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 9 | 1 | 17 | 17 |
Avg. Estimate | 38.93B | 37.71B | 145.23B | 165.86B |
Low estimate | 37.3B | 37.71B | 138.21B | 153.97B |
High estimate | 41.06B | 37.71B | 153.42B | 181.4B |
Year ago sales | 5.07B | 35.99B | 19.93B | 145.23B |
Sales growth (year/est) | 668.30% | 4.80% | 628.70% | 14.20% |
Earnings history | 31/03/2023 | 30/06/2023 | 30/09/2023 | 31/12/2023 |
---|
Est. EPS | 1.92 | 1.68 | 1.46 | 1.62 |
Actual EPS | 2.59 | 0.85 | 1.25 | 5.33 |
Difference | 0.67 | -0.83 | -0.21 | 3.71 |
Surprise % | 34.90% | -49.40% | -14.40% | 229.00% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | 1.3 | 1.19 | 6.26 | 8.05 |
7 days ago | 1.3 | 1.19 | 6.26 | 8.05 |
30 days ago | 3.3 | 2.85 | 6.1 | 8.38 |
60 days ago | 3.3 | 2.85 | 6.1 | 8.38 |
90 days ago | 3.06 | 3.07 | 6.2 | 10.67 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | BIOCON.NS | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -49.80% | N/A | N/A | N/A |
Next qtr. | 40.00% | N/A | N/A | N/A |
Current year | 63.00% | N/A | N/A | N/A |
Next year | 28.60% | N/A | N/A | N/A |
Next 5 years (per annum) | 62.70% | N/A | N/A | N/A |
Past 5 years (per annum) | 2.83% | N/A | N/A | N/A |